# Biological Interpretation of TCGA-BRCA Molecular Subtypes

## Overview

Unsupervised clustering of TCGA-BRCA RNA-Seq expression profiles identified three major molecular subtypes of breast cancer using PCA and K-means clustering.

The clustering patterns were biologically validated using known breast cancer subtype marker genes.

---

# Identified Molecular Subtypes

| Cluster | Assigned Subtype |
|---|---|
| Cluster 0 | Basal-like |
| Cluster 1 | Luminal B |
| Cluster 2 | Luminal A |

---

# Marker Gene Interpretation

## Luminal A Subtype

The Luminal A subtype showed elevated expression of:

- ESR1
- PGR
- GATA3
- FOXA1

These genes are associated with estrogen receptor signaling and luminal epithelial differentiation.

Luminal A tumors are generally:

- Hormone receptor positive
- Less proliferative
- Clinically associated with better prognosis

Lower expression of proliferation markers such as MKI67 further supports the Luminal A phenotype.

---

# Luminal B Subtype

The Luminal B subtype demonstrated:

- Increased MKI67 expression
- Elevated ERBB2 expression
- Intermediate ESR1 expression

These tumors are characterized by:

- Higher proliferation
- Increased aggressiveness
- Partial hormone receptor positivity

The elevated MKI67 expression suggests enhanced cell-cycle activity compared to Luminal A tumors.

---

# Basal-like Subtype

The Basal-like cluster showed strong expression of:

- EGFR
- KRT5

This subtype is associated with:

- Triple-negative breast cancer biology
- Aggressive clinical behavior
- Poorer prognosis

Basal-like tumors typically lack estrogen and progesterone receptor signaling and exhibit basal epithelial characteristics.

---

# Principal Component Analysis

PCA revealed clear separation between molecular subtypes, indicating distinct transcriptional programs across breast cancer subgroups.

The separation observed in PCA space supports the robustness of the clustering approach.

---

# Heatmap Validation

Subtype-specific heatmap analysis confirmed that canonical breast cancer marker genes were differentially expressed across clusters.

These expression signatures matched known biological characteristics of TCGA-BRCA intrinsic subtypes.

---

# Clinical Relevance

The identified subtype patterns may help:

- Stratify breast cancer patients
- Predict prognosis
- Identify therapeutic targets
- Support precision oncology approaches

---

# Conclusion

This study demonstrates that unsupervised transcriptomic analysis of TCGA-BRCA data can successfully recover biologically meaningful molecular subtypes.

The integration of clustering, PCA, heatmaps, and clinical information provides a robust framework for breast cancer subtype characterization.